{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:28:22Z","timestamp":1788906502454,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.jaad.2008.01.007","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T17:35:23Z","timestamp":1208453723000},"page":"796-801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigus"],"prefix":"10.1016","volume":"58","author":[{"given":"Annette","family":"Czernik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst H.","family":"Beutner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Bystryn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2008.01.007_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0923-1811(99)00016-X","article-title":"Autoimmunity against desmosomal cadherins in pemphigus","volume":"20","author":"Amagai","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2008.01.007_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.0022-202X.2004.23930.x","article-title":"IVIg treatment of pemphigus: how it works and how to use it","volume":"125","author":"Bystryn","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2008.01.007_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/08916930600972016","article-title":"IVIg selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgaris","volume":"39","author":"Bystryn","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaad.2008.01.007_bib4","first-page":"627","article-title":"A model for the regulation of antibody synthesis by serum antibody","volume":"Vol. 1","author":"Bystryn","year":"1971"},{"key":"10.1016\/j.jaad.2008.01.007_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199901213400311","article-title":"Mechanism of intravenous immune globulin therapy in antibody mediated autoimmune disease","volume":"340","author":"Yu","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.01.007_bib6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0002-9440(10)61239-4","article-title":"Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in pemphigus","volume":"167","author":"Arredondo","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaad.2008.01.007_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1067\/mjd.2002.122735","article-title":"Treatment of pemphigus with intravenous immunoglobulin","volume":"47","author":"Bystryn","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2008.01.007_bib8","first-page":"48","article-title":"Serum levels of autoantibodies to desmoglein 3 in patients with therapy-resistant pemphigus vulgaris successfully treated with adjuvant intravenous immunoglobulins","volume":"84","author":"Herzog","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2008.01.007_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/clim.2002.5278","article-title":"Influence of IVIg therapy on autoantibody titers to desmoglein 1 in patients with pemphigus foliaceus","volume":"105","author":"Sami","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaad.2008.01.007_bib10","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.01.007_bib11","first-page":"1","article-title":"IgG subclass deficiency","volume":"1","author":"Buckley","year":"1998","journal-title":"Clin Focus on Primary Immune Deficiencies"},{"key":"10.1016\/j.jaad.2008.01.007_bib12","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1172\/JCI24394","article-title":"Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases","volume":"115","author":"Li","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2008.01.007_bib13","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.4049\/jimmunol.166.5.3266","article-title":"MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells","volume":"166","author":"Zhu","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2008.01.007_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00281-006-0054-z","article-title":"IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity","volume":"28","author":"Yoshida","year":"2006","journal-title":"Springer Semin Immunopathol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208001175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208001175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:10:25Z","timestamp":1759270225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962208001175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0190962208001175"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2008.01.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1163712.625492","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigus","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2008.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}